I first became interested in drugs to treat brain diseases with I was a pharmacy student at Northeastern in the early 1980s. After I got my PhD in medicinal chemistry at the University of California–San Francisco, I returned to Boston for a post-doctoral fellowship at Harvard Medical School. At the time, I was drawn to research on neurodegenerative diseases, such as Parkinson’s. But by 1987, I switched to neuropsychiatric diseases, and that’s what I’ve been focused on ever since.
Imagine having the ability to take a single pill, or have one injection, and be ready for an MRI, CT scan, and PET scan at the same time?
Posted in Biochemistry, Biology, Biotechnology, Chemistry and Chemical Biology
In recent years, a body of publications in the microbiology field has challenged all previous knowledge of how antibiotics kill bacteria.